Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues

Osteoarthritis (OA) is the most common joint disease, and good therapeutic results are often difficult to obtain due to its complex pathogenesis and diverse causative factors. After decades of research and exploration of OA, it has been progressively found that subchondral bone is essential for its pathogenesis, and pathological changes in subchondral bone can be observed even before cartilage lesions develop. Osteoclasts, the main cells regulating bone resorption, play a crucial role in the pathogenesis of subchondral bone. Subchondral osteoclasts regulate the homeostasis of subchondral bone through the secretion of degradative enzymes, immunomodulation, and cell signaling pathways. In OA, osteoclasts are overactivated by autophagy, ncRNAs, and Rankl/Rank/OPG signaling pathways. Excessive bone resorption disrupts the balance of bone remodeling, leading to increased subchondral bone loss, decreased bone mineral density and consequent structural damage to articular cartilage and joint pain. With increased understanding of bone biology and targeted therapies, researchers have found that the activity and function of subchondral osteoclasts are affected by multiple pathways. In this review, we summarize the roles and mechanisms of subchondral osteoclasts in OA, enumerate the latest advances in subchondral osteoclast-targeted therapy for OA, and look forward to the future trends of subchondral osteoclast-targeted therapies in clinical applications to fill the gaps in the current knowledge of OA treatment and to develop new therapeutic strategies.

• Publication year

  2024

• Venue

  Acta Biochimica et Biophysica Sinica

• Publication date

  2024-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3724/abbs.2024017PMID 38439665PMCID 11090848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bone circuitry and interorgan skeletal crosstalk

  2023cited by this paper
• Human osteoarthritic articular cartilage stem cells suppress osteoclasts and improve subchondral bone remodeling in experimental knee osteoarthritis partially by releasing TNFAIP3

  2023cited by this paper
• κ-Opioid receptor activation attenuates osteoarthritis synovitis by regulating macrophage polarization through the NF-κB pathway

  2023cited by this paper
• Paroxetine Attenuates Chondrocyte Pyroptosis and Inhibits Osteoclast Formation by Inhibiting NF-κB Pathway Activation to Delay Osteoarthritis Progression

  2023cited by this paper
• Bone angiocrine factors

  2023cited by this paper
• The role of mechano growth factor in chondrocytes and cartilage defects: a concise review

  2023cited by this paper
• Axial Compressive Loading Attenuates Early Osteoarthritis by Reducing Subchondral Bone Remodeling

  2023cited by this paper
• The Nrf2/HMGB1/NF-κB axis modulates chondrocyte apoptosis and extracellular matrix degradation in osteoarthritis

  2023cited by this paper
• Application of Biomaterials in Treating Early Osteonecrosis of the Femoral Head: Research Progress and Future Perspectives.

  2023cited by this paper
• Glycolytic enzyme PKM2 regulates cell senescence but not inflammation in the process of osteoarthritis

  2023cited by this paper
• The STING inhibitor C‐176 attenuates osteoclast‐related osteolytic diseases by inhibiting osteoclast differentiation

  2023cited by this paper
• Dental Pulp Stem Cell-Derived Exosomes Alleviate Mice Knee Osteoarthritis by Inhibiting TRPV4-Mediated Osteoclast Activation

  2023cited by this paper
• The role of autophagy in bone metabolism and clinical significance

  2023cited by this paper
• Total lignans from Vitex negundo seeds attenuate osteoarthritis and their main component vitedoin A alleviates osteoclast differentiation by suppressing ERK/NFATc1 signaling

  2023cited by this paper
• The Role of NRF2 in Bone Metabolism – Friend or Foe?

  2022cited by this paper
• Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments

  2022cited by this paper
• Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2

  2022cited by this paper
• The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies

  2022cited by this paper
• Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis

  2022cited by this paper
• Effects of β2 Integrins on Osteoclasts, Macrophages, Chondrocytes, and Synovial Fibroblasts in Osteoarthritis

  2022cited by this paper
• Osteoclasts, Master Sculptors of Bone.

  2022cited by this paper
• Runx2 and Nell-1 in dental follicle progenitor cells regulate bone remodeling and tooth eruption

  2022cited by this paper
• AZ-628 delays osteoarthritis progression via inhibiting the TNF-α-induced chondrocyte necroptosis and regulating osteoclast formation.

  2022cited by this paper
• Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors.

  2022cited by this paper
• Dual protective role of velutin against articular cartilage degeneration and subchondral bone loss via the p38 signaling pathway in murine osteoarthritis

  2022cited by this paper
• Retinoic acid receptor activation reduces metastatic prostate cancer bone lesions by blocking the endothelial-to-osteoblast transition.

  2022cited by this paper
• Roles of osteoclast-associated receptor in rheumatoid arthritis and osteoarthritis.

  2022cited by this paper
• Neratinib Exerts Dual Effects on Cartilage Degradation and Osteoclast Production in Osteoarthritis by Inhibiting the Activation of the MAPK/NF-κB Signaling Pathways.

  2022cited by this paper
• Osteocytes in bone aging: advances, challenges, and future perspectives.

  2022cited by this paper
• Endochondral Ossification Induced by Cell Transplantation of Endothelial Cells and Bone Marrow Stromal Cells with Copolymer Scaffold Using a Rat Calvarial Defect Model

  2021cited by this paper
• Supplementary Fig. 1

  2021cited by this paper
• Regulation of TNF-Induced Osteoclast Differentiation

  2021cited by this paper
• Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway

  2021cited by this paper
• Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF-κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis

  2021cited by this paper
• Osteoarthritis year in review 2021: epidemiology & therapy.

  2021cited by this paper
• Role of K+ and Ca2+-Permeable Channels in Osteoblast Functions

  2021cited by this paper
• Betaine Attenuates Osteoarthritis by Inhibiting Osteoclastogenesis and Angiogenesis in Subchondral Bone

  2021cited by this paper
• Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion

  2021cited by this paper
• Cell Interplay in Osteoarthritis

  2021cited by this paper
• Roles for B[a]P and FICZ in subchondral bone metabolism and experimental temporomandibular joint osteoarthritis via the AhR/Cyp1a1 signaling axis

  2021cited by this paper
• Osteocyte Dysfunction in Joint Homeostasis and Osteoarthritis

  2021cited by this paper
• Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways

  2021cited by this paper
• miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis

  2021cited by this paper
• Paget’s Disease of Bone: Osteoimmunology and Osteoclast Pathology

  2021cited by this paper
• The role of autophagy in bone homeostasis

  2021cited by this paper
• Discovery of the RANKL/RANK/OPG system

  2021cited by this paper
• RANKL as the master regulator of osteoclast differentiation

  2021cited by this paper
• USP13 mediates PTEN to ameliorate osteoarthritis by restraining oxidative stress, apoptosis and inflammation via AKT-dependent manner.

  2021cited by this paper
• A review on osteoclast diseases and osteoclastogenesis inhibitors recently developed from natural resources.

  2020cited by this paper
• Osteoarthritis Year in Review 2020: Epidemiology & Therapy.

  2020cited by this paper
• Noncoding RNAs in subchondral bone osteoclast function and their therapeutic potential for osteoarthritis

  2020cited by this paper
• Less mechanical loading attenuates osteoarthritis by reducing cartilage degeneration, subchondral bone remodelling, secondary inflammation, and activation of NLRP3 inflammasome

  2020cited by this paper
• Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis

  2020cited by this paper
• Osteoclast differentiation by RANKL and OPG signaling pathways

  2020cited by this paper
• Osteoblast-Osteoclast Communication and Bone Homeostasis

  2020cited by this paper
• Osteoclast Multinucleation: Review of Current Literature

  2020cited by this paper
• Mechanisms of bone development and repair

  2020cited by this paper
• Ruboxistaurin maintains the bone mass of subchondral bone for blunting osteoarthritis progression by inhibition of osteoclastogenesis and bone resorption activity.

  2020cited by this paper
• Osteoclast-associated receptor blockade prevents articular cartilage destruction via chondrocyte apoptosis regulation

  2020cited by this paper
• Irisin inhibits osteocyte apoptosis by activating the Erk signaling pathway in vitro and attenuates ALCT-induced osteoarthritis in mice.

  2020cited by this paper
• The Role of Autophagy and Mitophagy in Bone Metabolic Disorders

  2020cited by this paper
• Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption

  2020cited by this paper
• Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis

  2020cited by this paper
• Amyloid β peptide promotes bone formation by regulating Wnt/β‐catenin signaling and the OPG/RANKL/RANK system

  2020cited by this paper
• Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development.

  2020cited by this paper
• Mechanically-induced Osteophyte in the Rat Knee.

  2020cited by this paper
• The Osteocyte: New Insights.

  2020cited by this paper
• miR-21 promotes osteoclastogenesis through activation of PI3K/Akt signaling by targeting Pten in RAW264.7 cells

  2020cited by this paper
• PP121 suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo.

  2020cited by this paper
• Endothelial Cell Calcium Signaling During Barrier Function and Inflammation.

  2019cited by this paper
• Interleukin-1β signaling in osteoarthritis - chondrocytes in focus.

  2019cited by this paper
• Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain

  2019cited by this paper
• MiR-146a-5p Expression in Peripheral CD14+ Monocytes from Patients with Psoriatic Arthritis Induces Osteoclast Activation, Bone Resorption, and Correlates with Clinical Response

  2019cited by this paper
• IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis.

  2019cited by this paper
• Paget’s Disease of Bone

  2019cited by this paper
• Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB–NFATc1 signal pathway

  2019cited by this paper
• Pro-inflammatory Cytokines and Osteocytes

  2019cited by this paper
• The Emerging Role of Osteocytes in Cancer in Bone

  2019cited by this paper
• Endothelial proteolytic activity and interaction with non-resorbing osteoclasts mediate bone elongation

  2019cited by this paper
• Isorhamnetin attenuates osteoarthritis by inhibiting osteoclastogenesis and protecting chondrocytes through modulating reactive oxygen species homeostasis

  2019cited by this paper
• MicroRNA-29b Enhances Osteoclast Survival by Targeting BCL-2-Modifying Factor after Lipopolysaccharide Stimulation

  2019cited by this paper
• Journal of Bone and Mineral Research

  2019cited by this paper
• Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway

  2019cited by this paper
• Artesunate, an Anti-Malaria Agent, Attenuates Experimental Osteoarthritis by Inhibiting Bone Resorption and CD31hiEmcnhi Vessel Formation in Subchondral Bone

  2019cited by this paper
• CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice

  2019cited by this paper
• Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo.

  2019cited by this paper
• Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases

  2019cited by this paper
• Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review

  2019cited by this paper
• Wnt signaling: a promising target for osteoarthritis therapy

  2019cited by this paper
• Activation of ROS/MAPKs/NF‐κB/NLRP3 and inhibition of efferocytosis in osteoclast‐mediated diabetic osteoporosis

  2019cited by this paper
• A Revised Perspective of Skeletal Stem Cell Biology

  2019cited by this paper
• Osteoarthritis is a serious disease.

  2019cited by this paper
• Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis

  2019cited by this paper
• Gypenoside inhibits RANKL‐induced osteoclastogenesis by regulating NF‐κB, AKT, and MAPK signaling pathways

  2018cited by this paper
• Osteocyte regulation of bone and blood.

  2018cited by this paper
• GIT1 contributes to autophagy in osteoclast through disruption of the binding of Beclin1 and Bcl2 under starvation condition

  2018cited by this paper
• C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast‐inducing chemokine CXCL10

  2018cited by this paper
• Wear particles enhance autophagy through up-regulation of CD147 to promote osteoclastogenesis

  2018cited by this paper
• Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling.

  2018cited by this paper
• Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro

  2018cited by this paper

• Dental Pulp-Derived Stem Cells in Mitigating Inflammatory Arthritis and Their Mechanisms in Conjunction with Oral Diseases.

  2026cites this paper
• Retinol Binding Protein 4 Promotes Chondrocyte and Osteoclast Differentiation.

  2026cites this paper
• Luteolin reprograms macrophage polarization via the STING-TBK1 pathway to accelerate bone repair.

  2026cites this paper
• The TRAF6/SPP1 axis participates in osteoarthritis progression through regulating the catabolism and anabolism of cartilage matrix.

  2026cites this paper
• KLF2 interacts with AP-1 to negatively affect osteoclast differentiation and activity.

  2026cites this paper
• Pathogenesis and therapeutic strategies of osteoarthritis: roles of immune cells, inflammatory mediators, and pathogenic signaling pathways

  2026cites this paper
• Association between the cartilage volume and bone mineral density in symptomatic knee osteoarthritis and the mediating role of bone mineral content

  2026cites this paper
• Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases

  2026cites this paper
• The dual role of extracellular vesicles in OA: Pathological mediators, diagnostic biomarkers, and therapeutic targets.

  2026cites this paper
• Integrated network pharmacology reveals the mechanism of action of Xianlinggubao prescription for inflammation in osteoarthritis

  2025cites this paper
• 软骨-骨交互作用的病理机制：动物实验研究骨关节炎的新视角

  2025cites this paper
• The V-ATPase a3 subunit deficiency affects osteoarthritis via mTOR-Mediated autophagy levels in subchondral bone.

  2025cites this paper
• [Research progress on the mechanism of moxibustion in the treatment of knee osteoarthritis in the past decade].

  2025cites this paper
• Pathophysiological Insights Into the Role of Osteoclasts in Osteoarthritis: Mechanisms, Therapeutic Targets, and Future Directions

  2025cites this paper
• Insights into Vascular Changes in Hip Degenerative Disorders: An Observational Study

  2025cites this paper
• Natural products in the treatment of osteoarthritis: Current status and prospects

  2025cites this paper
• Therapeutic extracellular vesicles enriched with SNHG5 reprogram autophagy and macrophage polarization in osteoarthritis.

  2025cites this paper
• Forsythoside B protects cartilage and subchondral bone in osteoarthritis by regulating the Nrf2/NF - κ B signaling pathway.

  2025cites this paper
• Up-regulation of peripheral and central CGRP expression combined with subchondral bone remodeling in rat MIA-induced TMJOA model

  2025cites this paper
• Interaction Between Activating Transcription Factor 4 and Interleukin 6 Dictates Osteoclast Differentiation and Activity

  2025cites this paper
• Purinergic signaling in osteoarthritis: Mechanistic insights into pathogenesis and therapeutic targeting

  2025cites this paper
• Kartogenin-loaded chitosan composite scaffold with cartilage-mimetic microstructure for layered osteochondral repair and cartilage phenotype maintenance

  2025cites this paper
• Extracellular vesicles in osteoarthritis: mechanisms, therapeutic potential, and diagnostic applications

  2025cites this paper
• Unraveling the Molecular Mechanisms of Osteoarthritis: The Potential of Polyphenols as Therapeutic Agents

  2025cites this paper
• The communication role of extracellular vesicles in the osteoarthritis microenvironment

  2025cites this paper
• The ganglioside GD3 and its Synthase (ST8SIA1) as novel senescence markers associated with osteoarthritis

  2025cites this paper
• Pyroptosis for osteoarthritis treatment: insights into cellular and molecular interactions inflammatory

  2025cites this paper
• Molecular Mechanisms and Therapeutic Role of Intra-Articular Hyaluronic Acid in Osteoarthritis: A Precision Medicine Perspective

  2025cites this paper
• FGF8 promotes lipid droplet accumulation via the FGFR1/p-p38 axis in chondrocytes

  2025cites this paper
• Intelligent Manufacturing for Osteoarthritis Organoids

  2025cites this paper
• Subchondral injection of human umbilical cord mesenchymal stem cells ameliorates knee osteoarthritis by inhibiting osteoblast apoptosis and TGF-beta activity

  2025cites this paper
• Advances in Molecular Research on Hip Joint Impingement—A Vascular Perspective

  2024cites this paper
• Association of blood vitamin A with osteoarthritis: a nationally representative cross-sectional study

  2024cites this paper
• Bioactive Compounds in Osteoarthritis: Molecular Mechanisms and Therapeutic Roles

  2024cites this paper
• Battling pain from osteoarthritis: causing novel cell death

  2024cites this paper